Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""de Kroon CD"" wg kryterium: Autor


Tytuł :
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Autorzy :
Krämer P; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
Talhouk A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
Brett MA; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Chiu DS; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Cairns ES; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
Scheunhage DA; Department of Pathology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.
Hammond RFL; Barts Health National Health Service Trust, Department of Pathology, London, United Kingdom.
Farnell D; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Nazeran TM; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Grube M; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
Xia Z; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Senz J; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Leung S; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Feil L; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
Pasternak J; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
Dixon K; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Hartkopf A; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
Krämer B; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
Brucker S; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
Heitz F; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.; Charité Campus Virchow-Klinikum, Department for Gynecology with the Center for Oncologic Surgery, Berlin, Germany.
du Bois A; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.
Harter P; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.
Kommoss FKF; Heidelberg University Hospital, Institute of Pathology, Heidelberg, Germany.
Sinn HP; Heidelberg University Hospital, Institute of Pathology, Heidelberg, Germany.
Heublein S; Department of Obstetrics and Gynecology, Heidelberg University Hospital, Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany.
Kommoss F; Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany.
Vollert HW; Department of Obstetrics and Gynecology, Medizin Campus Bodensee, Friedrichshafen, Germany.
Manchanda R; Barts CRUK Cancer Centre, Wolfson Institute of Preventative Medicine, Queen Mary University of London, Charterhouse Square, London, United Kingdom.; Department of Gynaecological Oncology, St. Bartholomew's Hospital, London, United Kingdom.
de Kroon CD; Department of Gynecology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.
Nijman HW; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
de Bruyn M; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Thompson EF; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Bashashati A; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; School of Biomedical Engineering, University of British Columbia, Vancouver, British Columbia, Canada.
McAlpine JN; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
Singh N; Barts Health National Health Service Trust, Department of Pathology, London, United Kingdom.
Tinker AV; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.
Staebler A; University Hospital Tuebingen, Institute of Pathology and Neuropathology, Tuebingen, Germany.
Bosse T; Department of Pathology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.
Kommoss S; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
Anglesio MS; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada. .; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Oct 15; Vol. 26 (20), pp. 5400-5410. Date of Electronic Publication: 2020 Jul 31.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial.
Autorzy :
Deken MM; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
van Doorn HC; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
Verver D; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
Boogerd LSF; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
de Valk KS; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Rietbergen DDD; Department of Radiology, Section Nuclear Medicine, Leiden University Medical Center, Leiden, the Netherlands; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
van Poelgeest MIE; Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
de Kroon CD; Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
Beltman JJ; Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
van Leeuwen FWB; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands.
Braak JPBM; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
de Geus-Oei LF; Department of Radiology, Section Nuclear Medicine, Leiden University Medical Center, Leiden, the Netherlands.
van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Burggraaf J; Centre for Human Drug Research, Leiden, the Netherlands.
Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Gaarenstroom KN; Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2020 Oct 08. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Short-term surgical complications after radical hysterectomy-A nationwide cohort study.
Autorzy :
Wenzel HHB; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Kruitwagen RFPM; Department of Obstetrics and Gynecology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
Nijman HW; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Bekkers RLM; Department of Obstetrics and Gynecology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.; Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, the Netherlands.
van Gorp T; Department of Obstetrics and Gynecology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
de Kroon CD; Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
van Lonkhuijzen LRCW; Department of Gynecological Oncology, Amsterdam University Medical Center-Center for Gynecological Oncology Amsterdam, Amsterdam, the Netherlands.
Massuger LFAG; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
Smolders RGV; Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, the Netherlands.
van Trommel NE; Department of Gynecological Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
Yigit R; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Zweemer RP; Department of Gynecological Oncology, University Medical Center, Utrecht Cancer Center, Utrecht, the Netherlands.
van der Aa MA; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
Pokaż więcej
Źródło :
Acta obstetricia et gynecologica Scandinavica [Acta Obstet Gynecol Scand] 2020 Jul; Vol. 99 (7), pp. 925-932. Date of Electronic Publication: 2020 Feb 06.
Typ publikacji :
Journal Article
MeSH Terms :
Hysterectomy/*methods
Postoperative Complications/*epidemiology
Uterine Cervical Neoplasms/*epidemiology
Uterine Cervical Neoplasms/*surgery
Adult ; Female ; Humans ; Lymph Node Excision ; Netherlands/epidemiology ; Prospective Studies ; Registries
Czasopismo naukowe
Tytuł :
Ovarian tissue cryopreservation: Low usage rates and high live-birth rate after transplantation.
Autorzy :
Hoekman EJ; Department of Gynecology and IVF, Leiden University Medical Center, Leiden, The Netherlands.
Louwe LA; Department of Gynecology and IVF, Leiden University Medical Center, Leiden, The Netherlands.
Rooijers M; Department of Gynecology and IVF, Leiden University Medical Center, Leiden, The Netherlands.
van der Westerlaken LAJ; Department of Gynecology and IVF, Leiden University Medical Center, Leiden, The Netherlands.
Klijn NF; Department of Gynecology and IVF, Leiden University Medical Center, Leiden, The Netherlands.
Pilgram GSK; Department of Gynecology and IVF, Leiden University Medical Center, Leiden, The Netherlands.
de Kroon CD; Department of Gynecology and IVF, Leiden University Medical Center, Leiden, The Netherlands.
Hilders CGJM; Department of Gynecology, Reinier de Graaf Hospital, Delft, The Netherlands.
Pokaż więcej
Źródło :
Acta obstetricia et gynecologica Scandinavica [Acta Obstet Gynecol Scand] 2020 Feb; Vol. 99 (2), pp. 213-221. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article
MeSH Terms :
Birth Rate*
Antineoplastic Agents/*adverse effects
Cryopreservation/*methods
Fertility Preservation/*methods
Ovary/*transplantation
Adolescent ; Adult ; Child ; Female ; Humans ; Netherlands ; Primary Ovarian Insufficiency/etiology ; Primary Ovarian Insufficiency/surgery ; Quality of Life ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Germline BRCA -Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.
Autorzy :
de Jonge MM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Ritterhouse LL; Division of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois.
de Kroon CD; Department of Gynaecology, Leiden University Medical Center, Leiden, the Netherlands.
Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Segal JP; Division of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois.
Puranik R
Hollema H; Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands.
Rookus MA; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
van Leeuwen FE; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Howitt BE; Department of Pathology, Stanford University School of Medicine, Stanford, California.
Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. .
Pokaż więcej
Corporate Authors :
HEBON Group
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 15; Vol. 25 (24), pp. 7517-7526. Date of Electronic Publication: 2019 Sep 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Germ-Line Mutation*
Loss of Heterozygosity*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Biomarkers, Tumor/*genetics
Endometrial Neoplasms/*genetics
Endometrial Neoplasms/*pathology
Adult ; Aged ; Cohort Studies ; Endometrial Neoplasms/classification ; Female ; Humans ; Middle Aged ; Neoplasm Grading
Czasopismo naukowe
Tytuł :
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer.
Autorzy :
Heeren AM; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
van Luijk IF; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Lakeman J; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Pocorni N; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Kole J; Laboratory for Physiology, Institute for Cardiovascular Research, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
de Menezes RX; Department of Epidemiology and Biostatistics, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Kenter GG; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
de Kroon CD; Department of Gynecology, Leiden University Medical Center, Leiden, The Netherlands.
Jordanova ES; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Nov; Vol. 68 (11), pp. 1759-1767. Date of Electronic Publication: 2019 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymphocytes, Tumor-Infiltrating/*immunology
Neoadjuvant Therapy/*methods
T-Lymphocytes, Regulatory/*immunology
Uterine Cervical Neoplasms/*drug therapy
Uterine Cervical Neoplasms/*immunology
Adult ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Pilot Projects ; Prognosis ; Retrospective Studies ; Uterine Cervical Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Ovarian function after ovarian transposition and additional pelvic radiotherapy: A systematic review.
Autorzy :
Hoekman EJ; Leiden University Medical Center, Department of Gynecology, Leiden, South Holland, the Netherlands. Electronic address: .
Broeders EABJ; Leiden University Medical Center, Department of Gynecology, Leiden, South Holland, the Netherlands.
Louwe LA; Leiden University Medical Center, Department of Gynecology, Leiden, South Holland, the Netherlands.
Nout RA; Leiden University Medical Center, Department of Radiotherapy, Leiden, South Holland, the Netherlands.
Jansen FW; Leiden University Medical Center, Department of Gynecology, Leiden, South Holland, the Netherlands.
de Kroon CD; Leiden University Medical Center, Department of Gynecology, Leiden, South Holland, the Netherlands.
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2019 Aug; Vol. 45 (8), pp. 1328-1340. Date of Electronic Publication: 2019 Mar 05.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Brachytherapy/*adverse effects
Ovary/*radiation effects
Pelvic Neoplasms/*radiotherapy
Radiation Injuries/*prevention & control
Aged ; Brachytherapy/methods ; Female ; Humans ; Middle Aged ; Ovarian Function Tests/methods ; Ovary/pathology ; Ovary/surgery ; Pelvic Neoplasms/pathology ; Radiotherapy Dosage ; Recovery of Function ; Risk Assessment
Czasopismo naukowe
Tytuł :
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Autorzy :
de Jonge MM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Auguste A; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.
van Wijk LM; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Schouten PC; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Meijers M; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Ter Haar NT; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Nout RA; Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
Glaire MA; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Church DN; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.
Vrieling H; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Job B; Plateforme de Bioinformatique, UMS AMMICA, Gustave Roussy Cancer Center, Villejuif, France.
Boursin Y; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.
de Kroon CD; Department of Gynecology, Leiden University Medical Center, Leiden, The Netherlands.
Rouleau E; Department of Genetics, Gustave Roussy Cancer Center, Villejuif, France.
Leary A; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.
Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. .
Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. .
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Feb 01; Vol. 25 (3), pp. 1087-1097. Date of Electronic Publication: 2018 Nov 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Endometrial Neoplasms/*genetics
Endometrium/*metabolism
Homologous Recombination/*genetics
Rad51 Recombinase/*genetics
Aged ; BRCA1 Protein/genetics ; BRCA1 Protein/metabolism ; BRCA2 Protein/genetics ; BRCA2 Protein/metabolism ; Comparative Genomic Hybridization ; DNA Breaks, Double-Stranded/drug effects ; DNA Breaks, Double-Stranded/radiation effects ; Endometrial Neoplasms/drug therapy ; Endometrial Neoplasms/pathology ; Endometrium/drug effects ; Endometrium/pathology ; Female ; High-Throughput Nucleotide Sequencing/methods ; Homologous Recombination/drug effects ; Humans ; Middle Aged ; Neoplasm Grading ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Prospective Studies ; Rad51 Recombinase/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies